Pharmaceuticals

Global Antisense and RNAi Therapeutics Market 2015-2019

  • TEC150098
  • 70 Pages
  • November 2014
  • Pharmaceuticals
About Antisense and RNAi Therapeutics
Antisense and RNAi therapeutics are new innovative therapeutics options that are used in the treatment of serious chronic and rare diseases. RNAi is a RNA-based gene silencing process in which RNA molecules inhibit gene expression by destructing definite mRNA molecules. Antisense technology involves the synthesis of a strand of nucleic acid that would bind to an mRNA or to a splicing site on pre-mRNA and inactivates it effectively. RNAi and antisense are two predominant technologies used by pharmaceutical companies, research institutes, and others for various applications such as research, diagnostics, and therapeutics. RNAi therapeutics have a large scope in the treatment of diseases such as cancer and neurodegenerative disorders. There are two types of RNA molecules used in the RNAi technology: miRNA and siRNA.

TechNavio's analysts forecast the Global Antisense and RNAi Therapeutics market to grow at a CAGR of 26.79 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Antisense and RNAi Therapeutics market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of antisense and RNAi therapeutics used for the treatment of various serious chronic diseases including:
Infectious diseases
Cardiovascular diseases
Kidney diseases
Cancer
Metabolic disorders
Others
The report also covers the two main technologies, i.e., Antisense and RNAi technology, which are used by vendors to develop antisense and RNAi therapeutics.
TechNavio's report, the Global Antisense and RNAi Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Antisense and RNAi Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
APAC
EMEA
Key Vendors
Alnylam Pharmaceuticals
Isis Pharmaceuticals
Sanofi
Tekmira Pharmaceuticals
Other Prominent Vendors

Acuitas Therapeutics
Allergan
Antisense Therapeutics
Ascletis
AstraZeneca
Atlantic Pharmaceuticals
Benitec Biopharma
Biogen Idec
Bristol-Myers Squibb
Dainippon Sumitomo Pharma
Dicerna Pharmaceuticals
Enzon Pharmaceuticals
F. Hoffmann-La Roche
Glaxosmithkline
Gradalis
iCo Therapeutics
Kyowa Hakko Kirin
Marina Biotech
Novartis
OncoGenex Pharmaceuticals
OPKO Health
Pfizer
Quark Pharmaceuticals
Regulus Therapeutics
Silence Therapeutics
Spectrum Pharmaceuticals
Sylentis
Takeda Pharmaceutical
Teva Pharmaceutical
The Medicines Company
TransDerm

Market Driver
Advances in Technology
For a full, detailed list, view our report
Market Challenge
Toxicity of Antisense and RNAi Molecules-based Drugs
For a full, detailed list, view our report
Market Trend
Increased Strategic Collaborations and Licensing Activities
For a full, detailed list, view our report
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Ovarian Cancer Drugs Market (Drugs and geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation

Ovarian cancer is cancer that affects the ovaries. According to the WHO, an estimated 2,38,700 women were diagnosed with ovarian cancer in 2012. The report analyzes the demand for ovarian ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

RNA-Based Therapeutics Asia-Pacific Market Research Report, 2014 - 2021

The RNA-based therapeutics involves broad range of the RNA-based technologies, which help the patients to diagnose or treat various chronic diseases. The RNA-based therapeutics play a crucial role in providing ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Urinary Tract Cancer (Types, Diagnostic Techniques, Treatment Procedures and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

One of the early symptoms of urinary tract cancer is the presence of blood in the urine, haematuria. As cited in WHO report urinary tract cancer was the ninth-most highly ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Organ Transplant Immunosuppressant Drugs Market (Therapeutics, Commercialized Products and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Organ transplant immunosuppressant drugs are the category of drugs which are administered to minimize the chances of organ rejection after transplantation. When a person undergoes any transplantation, the body recognizes ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Paediatric Vaccine Market (Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Vaccine provides protection against particular diseases by improving immunity. Vaccines are the biological preparations of weakened or killed microorganism, its surface proteins or its toxins. The global paediatric vaccine market ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Antiepileptic Drugs Market (Drug Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures. The epileptic seizures show recurring episodes and occur due to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>